Trevi Therapeutics Inc (TRVI)

R&D Expenses

$41.37M

TTM · Period ending: · USD

TRVI logo

TRVI R&D Expenses

Latest reported$41.37M
TRVI TTM R&D Expenses ($14.07M → $41.37M)
High-resolution chart · PNG

TRVI r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Trevi Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
41,371,000
35,608,000
33,478,000
36,613,000
37,752,000
38,384,000
39,377,000
36,567,000
31,666,000
27,487,000
23,683,000
21,482,000
20,928,000
20,189,000
19,834,000
21,696,000
20,645,000
22,040,000
22,984,000
23,365,000
23,475,000
21,898,000
22,328,000
20,591,000
21,413,000
22,020,000
19,339,000
19,039,000
17,136,000
15,047,000
14,072,000
11,147,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.